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Abstract
Background: To delineate sleep habits and problems in children with 22q11.2 deletion syndrome (22q11DS).
Methods: Thirty children, age 1–15 (mean 6.8) years, participated in the study,
which was an internet-based anonymous survey of parents of children with 22q11DS
administered via the 22q11.2 Foundation. The main outcome was the Childhood
Sleep Habits Questionnaire (CSHQ).
Results: Scores on the CSHQ demonstrated clinically significant sleep problems in
29 of the 30 children. When compared with previously reported normative values for
typically developing children of the same age, children with 22q11DS had significantly greater sleep problems. Only 30% of children had previously undergone sleep
study. While about half of children had tried a medication for sleep, it usually was
not felt to be helpful. In contrast, parents reported that behavioral interventions, such
as consistent bedtime routine and appropriate sleep environment, were helpful. This
is one of the first studies to specifically address sleep problems other than obstructive
sleep apnea in children with 22q11DS.
Conclusions: The findings suggest children with 22q11DS may have a higher risk
of experiencing clinical sleep problems, compared to typically developing children.
Consideration of additional screening and treatment of sleep disorders in children
with 22q11DS is warranted.
KEYWORDS
22q deletion syndrome, behavioral insomnia, childhood sleep habits questionnaire, pediatrics, sleep
disorders
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IN T RO D U C T ION

22q11.2 deletion syndrome (2q11DS; OMIM 188400) is
the most common chromosomal microdeletion syndrome.

Historically, individuals with DiGeorge syndrome, velocardiofacial syndrome, and conotruncal anomaly face syndrome
were thought to represent unique genetic disorders; however, with the evolution of cytogenetic and molecular genetic
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testing, it is known that a majority of persons with these disorders have a hemizygous microdeletion on the long arm of
chromosome 22. Additionally, 22q11DS is also known to be
the underlying cause of a portion of individuals clinically
diagnosed with Opitz G/BBB syndrome and Cayler cardiofacial syndrome. Due to this variable clinical presentation,
the often quoted prevalence of 1 in 4,000, is most likely an
underestimate. This variable clinical presentation most often
includes congenital heart defects, palate anomalies, characteristic facial features, developmental delays (DD) and/or intellectual disabilities (ID) and immune deficiency. Additional
clinical findings may include endocrine dysfunction, gastrointestinal anomalies, renal anomalies, hearing loss, skeletal
abnormalities, and ophthalmologic abnormalities. Practical
guidelines were published in 2011 to aid providers with medical management of these complexities (Bassett et al., 2011).
Despite extensive research into the more common clinical presentations associated with 22q11DS, little is known
about the specific sleep characteristics in this unique population. Previous studies have documented an increased risk of
obstructive sleep apnea (OSA) in this population (Crockett,
Goudy, Chinnadurai, & Wootten, 2014; Heike et al., 2007;
Kennedy et al., 2014; Silvestre, Tahiri, Paliga, & Taylor,
2014). Beyond OSA, one prior study reported a greater
prevalence of sleep problems in females with 22q11DS compared to males (Briegel, Schneider, & Schwab, 2007), and
there is a case report of continuous spikes and waves during
sleep (Valvo et al., 2012). Otherwise, to the best of our
knowledge, there are no systematic studies of specific clinical sleep problems in children with 22q11DS. Therefore, the
purpose of the present investigation was to evaluate sleep
habits and problems in children with 22q11DS.
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METHODS

2.1 | Editorial policies and ethical
compliance
The study was reviewed and approved by the Institutional
Review Board (ethics board) at Children's Mercy Hospital. It
complied with all recognized standards. Informed consent was
obtained from all participants prior to their inclusion in the study.
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Participants

Participants were recruited by distributing a survey invitation via the 22q11.2 Foundation, Inc. (22q.org and associated organization Facebook group). In addition, the
invitation encouraged others, such as professionals serving
families of children with 22q11DS, to inform parents of
the survey. The survey was web based, anonymous with
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no identifiers collected, and responses were recorded and
stored on a secure server in a Research Electronic Data
Capture (REDCap) database. Inclusion criteria included:
the respondent was a parent over the age of 18, the parent has a child with 22q11DS between the ages of 1 and
18 years old, and the parent has access to the Internet. There
were no exclusion criteria other than age. There were no direct benefits offered to parents or children for participation.
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Measures

Basic demographic information was elicited, including: age,
gender, country of residence, and which parent completed
the survey. Parents were asked if their child had any of the
following comorbidities or characteristics: congenital heart
disease, cleft palate (repaired or not), kidney disease, developmental delay, immunodeficiency, seasonal allergies,
eczema, seizure disorder requiring daily medications, and/
or reflux. Parents were asked if their child had ever had an
overnight sleep study, been diagnosed with sleep apnea, had
surgery to remove tonsils, or used a CPAP machine. Finally,
two open-ended questions asked about challenges and helpful interventions for their child's sleep.
Sleep characteristics were measured via the Children's
Sleep Habits Questionnaire (CSHQ). The CSHQ is a comprehensive, parent-reported 33-item questionnaire that measures sleep habits in eight sleep domains: Bedtime Resistance,
Sleep Onset Delay, Sleep Duration, Sleep Anxiety, Night
Wakings, Parasomnias, Sleep-Disordered Breathing, and
Daytime Sleepiness (Owens, Spirito, & McGuinn, 2000).
The CSHQ has been demonstrated to have adequate internal consistency, test‒retest reliability, and validity across
community and clinical samples (Owens et al., 2000). Each
question within subdomains asks about the frequency of a
specific sleep habit over the course of a week; some items
require reverse scoring, and all are summed to obtain total
subdomain scores. A total CSHQ score is also calculated,
with higher scores indicating more sleep problems and a
cutoff of 41 considered indicative of clinical sleep problems (Owens et al., 2000). This instrument has previously
been utilized in studies examining sleep characteristics of
children with neurodevelopmental disorders, such as autism spectrum disorders (Malow et al., 2006; Souders et al.,
2009), fetal alcohol syndrome (Chen, Olson, Picciano, Starr,
& Owens, 2012), and Down syndrome (Hoffmire, Magyar,
Connolly, Fernandez, & Wijngaarden, 2014). The CSHQ
has been validated in children aged 4–10 years, but has also
been utilized in children down to 1 year of age and into adolescence in previously published studies (Bassell, Phan, Leu,
Kronk, & Visootsak, 2015; Goldman, Richdale, Clemons, &
Malow, 2012; Goodlin-Jones, Sitnick, Tang, Liu, & Anders,
2008; Liu, Liu, Owens, & Kaplan, 2005).
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2.4

Statistical analysis

Results were summarized with mean and standard deviation
for continuous variables and frequencies for categorical variables. Scores on the CSHQ were tabulated for the entire sample
as well as those children aged 4–10 years for the purposes of
comparison with a previous large national sample of typically
developing 4- to 10-year-old children in the United States; published means, standard deviations, and sample size made summary independent samples t tests possible (Liu et al., 2005).
The assumption of equal variances was tested via Hartley test
in each comparison, and the p-values reported are based on if
the assumption was accepted or rejected. A total CSHQ score
of 41 was chosen as a cutoff to indicate clinically significant
sleep problems. Possible associations between sample characteristics and CSHQ scores were explored via backwards stepwise logistic regression. Results of open-ended questions were
analyzed in a qualitative fashion.
Statistical tests were two-sided with results considered
statistically significant at p < .05 level. This study was approved by the Institutional Review Board at Children's Mercy
Hospital. All data analyses were performed in SPSS (IBM
Corp. Released 2014. IBM SPSS Statistics for Windows,
Version 23.0. Armonk, NY: IBM Corp.).
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R E S U LTS

Forty-one parents viewed the online survey, with 31 completing it in its entirety. One of the participants was >18 years
of age and was excluded, leaving a final sample of 30 participants for analysis. Twenty-seven mothers and three
fathers completed the survey regarding their child. Most participants lived in the United States (n = 23), but there were
TABLE 1
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also responses from the United Kingdom (n = 2), Australia
(n = 1), Canada (n = 1), Ireland (n = 1), Netherlands (n = 1),
and Spain (n = 1). The sample was 53% female, and ranged
from 1 to 15 years old with a mean age of 6.8 years. Important
comorbidities included speech delay (n = 23), seasonal allergies (n = 14), congenital heart disease (n = 13), immunodeficiency (n = 12), cleft palate (n = 5 unrepaired and n = 4
repaired), reflux (n = 9), eczema (n = 6), epilepsy (n = 3),
growth hormone deficiency (n = 1), and hypothyroidism
(n = 1).
Nine (30%) participants had undergone sleep study in
the past, and only 6 (20%) of the 30 participants had been
diagnosed with obstructive sleep apnea. Seven children
(23%) had undergone tonsillectomy, and four (13%) used
CPAP. Sixteen (53%) children had previously used a medication for sleep; 11 (37%) had tried melatonin and 5 found
it helpful, 4 (13%) had tried supplemental iron and 1 found
it helpful, 1 (3%) had taken clonidine and did not find it
helpful, and no child had previously taken trazodone, gabapentin, or zolpidem.
Overall CSHQ results are presented in Table 1. The mean
total CSHQ score was significantly elevated at 57.2, with all
but one participant having a score >41. When the 22q group
aged 4–10 years was compared to previously published normative data for 4- to 10-year-old children, there were no significant differences in sleep schedule in terms of bedtime,
waketime, or sleep duration; in contrast, total CSHQ score
as well as all subdomains were significantly worse compared
to typically developing children. Within the age category of
4–10 years, all children with 22q11DS in our sample had
total CSHQ scores above 41, indicating clinically significant
sleep problems.
Potential associations between participant characteristics
and sleep problems were explored via backward stepwise

CSHQ scores of children with 22q compared to previously reported typically developing children. Values are mean (SD)
22q11DS, all
ages (n = 30)

Bedtime, hr
Waketime, hr

8.5 (0.8)

22q11DS, 4–10 years
(n = 13)
8.4 (0.6)

Typically developing sample,
4–10 years (n = 357–415)

p-value, 22q11DS 4–10 years versus
typically developing 4–10 years

8.4 (0.5)

1.000

6.6 (1.4)

6.2 (1.6)

6.9 (0.4)

.141

Sleep duration, hr

10.6 (2.1)

10.5 (1.7)

10.1 (0.6)

.414

Bedtime resistance

10.3 (3.6)

10.6 (3.8)

7.0 (1.8)

.005

Sleep onset delay

1.9 (0.9)

1.9 (0.9)

1.2 (0.5)

.016

Sleep duration

5.2 (1.9)

4.6 (1.3)

3.4 (0.9)

.006

Sleep anxiety

7.1 (1.7)

7.3 (1.9)

4.8 (1.4)

<.001

Night waking

5.8 (1.8)

5.8 (2.1)

3.4 (0.8)

.001

Parasomnias

11.2 (3.0)

10.6 (2.2)

8.1 (1.3)

.001

4.4 (1.8)

4.4 (1.9)

3.2 (0.6)

.042

Daytime sleepiness

14.7 (4.2)

14.0 (4.1)

9.7 (2.8)

.003

Total CSHQ

57.2 (9.9)

55.5 (8.5)

38.7 (5.5)

<.001

Sleep-disordered
breathing
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regression analysis and results are presented in Table 2.
Variables were retained in the model based on probability of F-to-remove>/=0.100. Younger age was associated
with more bedtime resistance (Beta = −0.460, p = .011),
night wakings (Beta = −0.327, p = .066), parasomnias
(Beta = −0.386, p = .020), and sleep-disordered breathing
(Beta = −0.390, p = .019), but less problems with sleep onset
delay (Beta = 0.322, p = .083). Female persons had more
sleep anxiety (Beta = 0.391, p = .042) and night wakings
(Beta = 0.468, p = .013). Children with a history of congenital heart disease (Beta = 0.361, p = .028) or developmental
delay (Beta = 0.471, p = .005) had more problems with sleep
duration. Immunodeficiency was associated with parasomnias (Beta = 0.532, p = .002) and sleep-disordered breathing
(Beta = 0.520, p = .003). Seasonal allergies were associated
with overall score (Beta = 0.419, p = .018), sleep anxiety
(Beta = 0.369, p = .054), and night wakings (Beta = 0.377,
p = .047). Eczema was associated with daytime sleepiness
(Beta = 0.307, p = .079). Epilepsy was associated with overall score (Beta = 0.452, p = .011) and daytime sleepiness
(Beta = 0.356, p = .044). Finally, reflux was associated with
overall score (Beta = 0.395, p = .019). Although many associations were found, as listed above, all of the final models

explained a very modest amount of variability in sleep scores
(ranging 10%–36%).
Finally, responses to open-ended questions were reviewed. Selected qualitative responses regarding sleep
challenges and interventions are provided in Table 3.
When asked, “What is the biggest sleep challenge your
child faces?”, responses included: sleeping independently
(n = 6), frequent nighttime awakenings (n = 5), anxiety or
fears (n = 4), bedtime resistance or difficulty falling asleep
(n = 3), restlessness or restless legs (n = 3), snoring or
sleep apnea (n = 3), daytime sleepiness (n = 2), irregularity in sleep schedule (n = 1), early morning awakenings
(n = 1), and bed-wetting (n = 1). When asked “What have
you found helpful for your child's sleep?”, common themes
were: cosleeping with parent (n = 5), white noise machine
(n = 4), consistent bedtime routine (n = 4), increasing daytime physical activity (n = 3), nothing (n = 3), keeping the
room cool and dark (n = 2). Individually, parents also reported rocking to sleep (n = 1), sleeping in their own bed
and room (n = 1), bath before bed (n = 1), soothing with
bottle (n = 1), reward system for staying in bed (n = 1),
essential oils (n = 1), okay to wake alarm (n = 1), and melatonin (n = 1).

TABLE 2

Relationship between patient characteristics and sleep problems. Predictors retained in the final model from stepwise regression
analysis are displayed. Values are B (SE)
CSHQ total

Bedtime resistance

Sleep onset delay

Sleep duration

Sleep anxiety

Age

—

−0.39 (0.14)

0.07 (0.03)

—

—

Gender

—

—

—

—

1.3 (0.6)

Congenital heart disease

—

—

—

1.3 (0.5)

—

Developmental delay

—

—

—

1.9 (0.6)

—

Immunodeficiency

—

—

—

—

—

Seasonal allergies

8.2 (3.2)

—

—

—

1.2 (0.6)

Eczema

—

—

—

—

—

Epilepsy

14.8 (5.3)

—

—

—

—

8.4 (3.3)

—

—

—

—

0.368

0.211

0.104

0.347

0.194

Night wakings

Parasomnias

Sleep-disordered breathing

Daytime sleepiness

Age

−0.14 (0.07)

−0.28 (0.11)

−0.17 (0.07)

—

Gender

1.6 (0.6)

—

—

—

Congenital heart disease

—

—

—

—

Developmental delay

—

—

—

—

Immunodeficiency

—

3.2 (0.9)

1.9 (0.5)

—

Seasonal allergies

1.3 (0.6)

—

—

—

Eczema

—

—

—

3.2 (1.7)

Epilepsy

—

—

—

4.9 (2.3)

Reflux
2

Model R

Reflux

—

—

—

—

Model R2

0.292

0.363

0.354

0.245
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TABLE 3

Selected qualitative responses regarding sleep
challenges and interventions
What is the biggest sleep challenge your child faces?
“Getting him to start winding down when it's bedtime. He is always
on the go and will often times want to go play more even though
it's time to settle down.”
“Sleep study shows he wakes up around 86 times a night. He stops
breathing around 8 times an hour and he physically wakes up to
where I have to wake up with him 10 times a night.”
“Going to sleep by themselves. My husband is with her every
night.”
“Our daughter has difficulty going to sleep and staying asleep. Her
mind is constantly going although we have tried Clonidine and
Melatonin. They work occasionally but our daughter awakens
more drowsy than if she hadn't been medicated. She sleep walks,
talks and eats.”
“Staying asleep once she falls asleep. She usually doesn't want
leave her room when she wakes because we've been pretty strict
about staying in her room but I often find her asleep on the floor
or when I go in in the morning she has ten books in her bed. She
also wakes up screaming at least a couple of times a week.”
“Seems to have trouble getting to sleep because of anxiety,
worrying about the next day's events.”
What have you found helpful for your child's sleep?
“To NOT allow him to sleep in mom and dads bed. He does so
much better when he sleeps on his own. We've also found keeping
the room cool and dark keeps him sleeping through the night.”
“Making sure he has an active day to help him sleep better at
night.”
“Keeping a consistent routine. TV is switched off after 7 p.m., we
read him a couple of books and give him plenty of cuddles before
bed.”
“Nothing apart from sharing a bed with myself or his dad.”
“We use a noise machine. It helps drown out other little noises that
stimulate and scare our daughter. She likes the nature sounds.”
“Using an 'okay to wake' alarm clock that changes colors in the
morning. She knows it has to be green for her to leave her room
and will stay in there if it hasn't changed usually, and often she
falls back to sleep after being up. I don't know if it helps her sleep
but it helps the rest of the family stay well-rested.”
“Nothing.”
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D IS C U SSION

22q11DS is the most common microdeletion syndrome.
Despite its relative commonality, the awareness and understanding of all facets encompassing this syndrome are continuing to be explored. Of the almost 200 characteristics that can
be seen in children with 22q11DS, the five most commonly
cited are DD/ID, congenital heart disease, palatal abnormalities, immune deficiency, and parathyroid issues/hypocalcemia.
Other than obstructive sleep apnea, clinical sleep problems have historically not been readily highlighted or systematically investigated for this population. There have been
several papers reporting on the increased risk specifically of
OSA in persons with 22q11DS compared to nonsyndromic
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children; often these studies are referencing obstructive sleep
concerns in relation to surgical correction of a cleft palate
or velopharyngeal insufficiency (Crockett et al., 2014; Heike
et al., 2007; Kennedy et al., 2014; Silvestre et al., 2014).
While awareness has been growing around the increased risk
of OSA in these persons, the existence, understanding, and
impact of other sleep problems in children with 22q11DS has
not previously been fully addressed. This is one of the first
studies to specifically address sleep problems other than OSA
in persons with 22q11DS.
The results of this study demonstrate that persons with
22q11DS potentially have a higher prevalence of clinically
meaningful sleep problems, even beyond OSA, compared to
typically developing children. All but one child in the current
sample had scores on their sleep habits questionnaire that exceeded the threshold for clinical sleep problems, and all subdomains of clinical sleep problems were elevated compared
to typically developing children. These data suggest that
providers caring for persons with 22q11DS should consider
inquiring not only about obstructive sleep apnea symptoms,
but additionally investigate whether concerns for other sleep
problems exist as well. To assist with this, routine screening
of persons with 22q11DS for sleep problems using validated
questionnaires (i.e., CSHQ or Pediatric Sleep Questionnaire)
may be helpful. If clinically significant sleep problems are
elicited, referral to sleep specialist may be beneficial.
Several characteristics were identified as potential predictors of sleep problems among children with 22q11DS, many
of which have also been observed in other populations. Our
age findings are expected, with bedtime resistance and parasomnias typically more prevalent in younger children, and
delayed sleep phase and psychophysiologic insomnia more
common among teenagers. Seasonal allergies and eczema
have both previously been shown to result in disrupted sleep
at night in children (Fishbein et al., 2015; Koinis-Mitchell
et al., 2015). Previous studies have demonstrated that children
with reflux have more difficulty falling and staying asleep at
night, adolescents with reflux treated with proton pump inhibitor experience improvement in sleep dysfunction, and reflux may contribute to obstructive sleep apnea (Ghaem et al.,
1998; Gunasekaran et al., 2009; Wasilewska, Kaczmarski, &
Debkowska, 2011; Wasilewska et al., 2012). It is not surprising that developmental delay was associated with more problems in sleep duration given the known high prevalence of
sleep problems in that population. Similarly, there is a known
bidirectional relationship between epilepsy and sleep problems in children (Ekinci, Isik, Gunes, & Ekinci, 2016; Jain,
Horn, Simakajornboon, & Glauser, 2013; Jain et al., 2012).
Interestingly, immunodeficiency was associated with more
sleep duration problems. In adults, immunodeficiency has
previously been shown to be related to decreased sleep duration, with T-cell counts, cytokine levels, and cytokine polymorphisms related to sleep disturbance (Lee et al., 2014).

6 of 8
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Given the high prevalence of immunodeficiency and autoimmune/atopic disease among children with 22q11DS, future
investigation into the intersection of the immune system and
sleep seems warranted.
Open-ended responses from parents were illuminating.
The issues that parents identified as their child's most challenging sleep problem spanned the entire spectrum rather
than focusing on just sleep-related breathing disorders. One
representative response was: “Our daughter has difficulty
going to sleep and staying asleep. Her mind is constantly
going although we have tried Clonidine and Melatonin. They
work occasionally but our daughter awakens more drowsy
[sic] than if she hadn't been medicated. She sleep walks,
talks and eats.” Parents also reported strategies that they
have found helpful with their child's sleep, and these largely
seemed to reflect known treatments for behavioral insomnia
of childhood, including consistent bedtime routine, ensuring an appropriate sleeping environment, and use of a good
morning light. For example, one parent reported: “Keeping a
consistent routine. TV is switched off after 7 p.m., we read
him a couple of books and give him plenty of cuddles before
bed.” Another reported: “Using an 'okay to wake' alarm clock
that changes colors in the morning. She knows it has to be
green for her to leave her room and will stay in there if it
hasn't changed usually, and often she falls back to sleep after
being up. I don't know if it helps her sleep but it helps the
rest of the family stay well-rested.” These parent-reported experiences suggest that behavioral treatments commonly used
in typically developing children or other special populations
may be beneficial for children with 22q11DS.
Interestingly, there were relatively few children in our
sample who had significant sleep interventions in the past.
Only about a third of children had undergone a sleep study
and even fewer diagnosed with sleep apnea, which is surprising given the known high prevalence of OSA in this population. Additionally, while about half of children had tried
a medication for sleep in the past, most parents did not feel
that the medication helped and almost all children still had
clinically meaningful sleep problems. This is potentially concerning given the well-established deleterious impact of OSA
on neurocognitive function (Hunter et al., 2016), with recent
studies demonstrating that children with untreated OSA have
reduced gray matter volume (Philby et al., 2017), evidence of
neuronal injury (Halbower et al., 2006), and increased neuronal recruitment (mental effort) to perform at similar levels compared to children without OSA (Kheirandish-Gozal,
Yoder, Kulkarni, Gozal, & Decety, 2014). These changes may
translate into real-word outcomes, such as affecting school
performance (Gozal, 1998) and contributing to daytime
behavioral challenges (Smith et al., 2016). Similar behavioral and cognitive effects may be seen with other untreated
sleep disorders in children, including restless legs syndrome
(Picchietti & Picchietti, 2008), chronic insomnia (Angriman,
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Caravale, Novelli, Ferri, & Bruni, 2015), and narcolepsy
(Rocca, Pizza, Ricci, & Plazzi, 2015). Intervention for sleep
disorders may be particularly important in children with underlying neurodevelopmental disorders, given that smaller
effects may result in larger real world functional impairment
due to lower baseline cognitive levels. These data suggest
that there is a need for additional screening and treatment of
sleep disorders in children with 22q11DS.
This study has several limitations. We measured sleep
habits and problems with the CSHQ, which is parent reported
and subjective. We did not have objective sleep metrics from
actigraphy or polysomnography. However, the CSHQ is a
standardized and validated tool which can be used to compare
across previous and future studies. In addition, subjective
clinical symptoms are often more important to families than
formal sleep study metrics. Another limitation of this study
is its cross-sectional design, which precludes any cause-effect inferences. Our sample size was limited, and we utilized
previously reported normative data rather than collecting
data for a new comparison group; that said, the normative
data were from a recent, large, national study. In addition,
the voluntary recruitment of participants via an online source
creates a significant selection bias for parents with a higher
educational level and greater motivation to seek services and
knowledge. This bias may have impacted our results by causing an increase in positive responders with incentive to report
positive findings in his/her child. Lastly, the demographics
may be skewed given the online nature of the study recruitment and survey toward a higher socioeconomic status.
While the results of the present investigation are novel
and of clinical importance, significant knowledge gaps on
this topic remain, highlighting the great potential and need
for future research. Larger prospective studies incorporating both subjective and objective measures are needed to
better elucidate sleep characteristics and underlying contributing factors among children with 22q11DS. This study
did not focus specifically on behavioral issues, such as autism spectrum disorder, which can be associated with children with 22q11DS; behavioral challenges during the day
may contribute to sleep difficulties, and vice versa. Future
studies are needed to determine the interaction of behavioral challenges and sleep quality in these children and its
subsequent relationship to underlying attention, affect, and
school performance. Another question for future research
includes assessing the children's sleep issues specifically
in relationship to their underlying health problems. One
example would be looking at children with 22q11DS and
congenital heart disease, and their sleep quality in relation
to development and medical interventions. It is unknown
whether there is a change in sleep patterns for these children
after surgical intervention or after requiring a prolonged
anesthesia or time on cardiopulmonary bypass; answers to
these questions may shed light on causality. Overall, there
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is a significant need for future research on this topic to continue and help fill the current knowledge gaps.
In conclusion, this is one of the first studies to specifically address sleep problems other than OSA in children with
22q11DS. The results of this study suggest that these children
may have a higher risk of having clinical sleep problems,
compared to typically developing children. The findings suggest there is a need for additional screening and treatment of
sleep disorders in children with 22q11DS. Larger prospective
studies are needed to better elucidate sleep characteristics
among children with 22q11DS and continue to fill the current knowledge gaps.
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